Biodesix Inc. (BDSX) Tops Q3 EPS by 5c

Biodesix Inc. (NASDAQ: BDSX) reported Q3 EPS of ($0.41), $0.05 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $7.37 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Estee Lauder shares jump as fiscal 2027 profit forecast tops estimates
• Coty (COTY) Misses Q4 EPS by 1c, offers outlook